Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,311 | -647 | -1,137 | -641 | -371 |
| Depreciation Amortization | 666 | 346 | 739 | 537 | 344 |
| Income taxes - deferred | -461 | -228 | -403 | -239 | -226 |
| Accounts receivable | -529 | 79 | -3,775 | -3,724 | -831 |
| Other Working Capital | -1,255 | -523 | -3,494 | -5,147 | -2,500 |
| Other Operating Activity | 724 | 31 | 4,250 | 4,060 | 1,049 |
| Operating Cash Flow | $-2,166 | $-942 | $-3,820 | $-5,155 | $-2,536 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -435 | -407 | -1,453 | -1,060 | -517 |
| Purchase Sale Intangibles | -450 | -450 | N/A | N/A | 0 |
| Other Investing Activity | -450 | -450 | 0 | 0 | 0 |
| Investing Cash Flow | $-885 | $-857 | $-1,453 | $-1,060 | $-517 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 237 | 237 | 237 |
| Financing Cash Flow | $0 | $0 | $237 | $237 | $237 |
| Beginning Cash Position | 4,615 | 4,615 | 9,650 | 9,650 | 9,650 |
| End Cash Position | 1,564 | 2,816 | 4,615 | 3,673 | 6,835 |
| Net Cash Flow | $-3,051 | $-1,799 | $-5,036 | $-5,978 | $-2,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,166 | -942 | -3,820 | -5,155 | -2,536 |
| Capital Expenditure | -435 | -407 | -1,453 | -1,060 | -517 |
| Free Cash Flow | -2,601 | -1,349 | -5,273 | -6,215 | -3,052 |